Table 2.
Placebo |
Cinnamon (肉桂 ròu guì) |
|||||
---|---|---|---|---|---|---|
n | Baseline | Final | n | Baseline | Final | |
BMId | 70 | 25.8 ± 0.3 | 25.6 ± 0.3 | 63 | 24.8 ± 0.4 | 24.6 ± 0.4 |
Fasting glucose, mmol/L | 73 | 8.57 ± 0.32 | 8.44 ± 0.34 | 64 | 8.85 ± 0.36 | 8.19 ± 0.29** |
2-hr glucose, mmol/L | 73 | 14.18 ± 0.60 | 13.74 ± 0.58 | 64 | 15.09 ± 0.57 | 13.30 ± 0.55*** |
Fasting insulin, mU/L | 72 | 21.64 ± 1.66 | 23.65 ± 3.02 | 63 | 24.25 ± 2.01 | 22.26 ± 2.08* |
2-hr insulin, mU/L | 73 | 86.43 ± 5.19 | 82.58 ± 4.84 | 59 | 93.13 ± 5.78 | 83.17 ± 4.53 |
HOMA-IR | 72 | 8.51 ± 0.80 | 9.12 ± 1.32 | 63 | 9.67 ± 0.90 | 8.32 ± 0.84** |
Fructosamine, μmol/L | 57 | 348 ± 9 | 338 ± 8 | 51 | 336 ± 8 | 319 ± 7* |
Systolic blood pressure, mmHg | 72 | 122.7 ± 1.5 | 126.2 ± 1.8¤ | 63 | 128.3 ± 1.9 | 131.1 ± 1.9 |
Diastolic blood pressure, mmHg | 72 | 75.9 ± 0.9 | 77.4 ± 1.0 | 63 | 78.2 ± 1.1 | 77.2 ± 1.1 |
Total cholesterol, mmol/L | 57 | 5.12 ± 0.12 | 5.05 ± 0.14 | 53 | 5.20 ± 0.14 | 4.96 ± 0.16* |
LDL cholesterol, mmol/L | 57 | 3.45 ± 0.09 | 3.35 ± 0.11 | 53 | 3.48 ± 0.14 | 3.25 ± 0.14** |
HDL cholesterol, mmol/L | 57 | 1.28 ± 0.04 | 1.21 ± 0.04¤¤ | 53 | 1.26 ± 0.04 | 1.17 ± 0.04** |
Triacylglycerols, mmol/L | 57 | 2.05 ± 0.17 | 2.48 ± 0.19¤¤¤ | 53 | 2.20 ± 0.21 | 2.58 ± 0.28* |
Mean ± SEM.
Placebo group – significantly different from baseline ¤p < 0.05; ¤¤p < 0.005; ¤¤¤p < 0.0001.
Cinnamon group – significantly different from baseline *p < 0.05;**p < 0.005;***p < 0.0001.
BMI = Body Mass Index.